- Silvio Tiziani (Chief Executive Officer)
- Chih Wei Teng (Chief Operations Officer)
- Wade Kruger (Commercialisation Officer)
CEO, CCRM Australia
Silvio Tiziani played a key role in the establishment of CCRM Australia after securing funding from Monash University, MTP Connect, CSIRO and The Victorian Government. Silvio’s skills focus on the specialised role of leading the strategic alliance with the Centre of Commercialisation of Regenerative Medicine (CCRM) and being Director of ARMI’s external engagement, strategic planning and communications. Silvio’s extensive knowledge of the research landscape is well utilised with his networks within industry, international organisations and the state and federal government.
Silvio has extensive experience in private and public organisations, with a focus on laboratory-based organisations in the academic, health and healthcare systems.
In addition to qualifications that include a Bachelor of Science from Swinburne University and a Masters of Business Administration from Monash University, Silvio is also a graduate of the Australian Institute of Company Directors (GAICD) and a Certified Professional with the Australia Human Resources Institute (CAHRI). Silvio has extensive experience in financial analysis and budget management, business development, strategic planning and corporate governance along with the interpersonal skills to lead staff.
Silvio also chairs the Ausbiotech Regenerative Medicine Advisory Group, comprising leading representatives from Australian industry and academia to provide specialist advice to Ausbiotech, Australia’s member based biotechnology organisation that promotes the global growth of Australian biotechnology.
Chih Wei Teng
COO, CCRM Australia
Chih Wei is the Chief Operations Officer at CCRM Australia, responsible for the development and operationalisation of CCRM Australia’s 5 Year strategy. In addition to his administrative role, Chih Wei actively works with biotechnology companies and academics to translate their innovation.
Chih Wei has completed a doctoral degree, researching how the translation of regenerative medicine can be improved with open collaborative innovation. His research showed that interdisciplinary collaboration result in new capabilities that not only improve translation outcomes but also support the development of competitive business models. Chih Wei has an MBA and a diploma thesis on business models of public versus private cord blood banking.
Prior to CCRM Australia, Chih Wei has worked for IBM for seven years where he handled portfolios of Energy and Utilities, Industrial Manufacturing as well as Healthcare and Life Sciences industries. In addition to his role at CCRM Australia, Chih Wei is also a Research Fellow at the Department of Management at Monash University where he works with industry on implementing Sustainable Procurement and research on the growth of SMEs.
Commercialisation Officer, CCRM Australia Attract
Wade is the Commercialisation Officer at CCRM Australia Attract, leading the specialised business services provided by the Attract Unit. Wade’s experience in biomedical, clinical research and project management brings immense value to assist customers and partners in industry and academia to commercialise regenerative medicine.
Wade has a Bachelor of Biomedical Sciences, Bachelor of Science with Honours (Pharmacology) and a PhD in Molecular Physiology. His passion for facilitating and streamlining quality clinical research has led him to various roles in supporting the advancement of clinical research, including working as the Manager of Research Business Development and Engagement at St Vincent’s Hospital Melbourne and as the Clinical Research Operations Consultant at Diabetes Technology Research Group.